Discovery Broadens Scope of Use of CRISPR Gene Editing
Combining two powerful therapeutic technologies may change the landscape of medical therapeutics.
Discovery of Antibody that Neutralizes All Known Variants of SARS-CoV-2 Could Lead to New Vaccines and Clinical Laboratory Treatments for COVID-19
Though only in early stages, findings could lead to a ‘therapeutic against current and newly-arising variants,’ say researchers.
N.W.T. testing discarded blood samples for COVID-19 antibodies
The territory says testing of discarded anonymous blood samples taken from April 1 onward will help it better understand how COVID-19 has affected residents.
Can You Diagnose a Bloodstream Infection in 2.5 Hours?
Rapid, sensitive sepsis diagnosis can now be performed with biphasic amplification in a dried blood matrix.
Researchers Develop Non-Invasive Clinical Laboratory Skin Test for Measuring Cholesterol
The study also may have found relationship between atherosclerosis and cholesterol.
New database brings together multiple brain maps in one place
The brain is a complex organ, and no one imaging mode can catch everything that's going on inside it. Over the years, multiple "brain maps" have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.
Now a team from The Neuro has brought together more than forty existing brain maps in one place.
Less than a Third of FDA Regulatory Actions Backed by Research
Less than a third of regulatory actions taken by the US Food and Drug Administration (FDA) are corroborated by published research findings or public assessments, finds a recently published study.
Comparative study on retracted publications explores whether COVID-19-related research is subject to a higher degree of scrutiny
In a recent research letter published in JAMA Network Open, a team of researchers compared the author characteristics and causes for manuscript retractions of coronavirus disease 2019 (COVID-19) and non-COVID-19 related research.
The magnitude and duration of the protective effect of prior infection and hybrid immunity against Omicron infection and severe disease
In a recent study posted to the medRxiv* preprint server, researchers reviewed the duration and magnitude of the protective effect of previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (PE) and hybrid immunity (HE, from previous infections and vaccinations) against SARS-CoV-2 Omicron variant of concern (VOC) infections and coronavirus disease 2019 (COVID-19) severity.
Ethics Not Only Allow but Demand Placebo in Some HIV Cure Trials
Is it ethical to test possible HIV cures by having subjects stop taking antiretroviral therapy and then giving them placebos rather than the experimental treatment?
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.